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FOREWORD
FOREWORD
The Local Drugs Task Forces were set up to
ensure a fully integrated response to the drug
problem in the worst hit areas which takes
account of the specific needs of those areas.
Of equal importance, the Task Force process
allows local communities - the people most
affected by the problem - to work with the
State Agencies and voluntary organisations in
designing and delivering that response.
Since their inception in 1997, the Task Forces have achieved a significant
number of successes, not least in reducing the feelings of isolation and
frustration previously experienced by many community and voluntary
organisations working at the coalface of the drug problem. These
organisations now feel that they are part of a co-ordinated and effective
response to drug misuse in their areas. While much still needs to be done,
we have nevertheless over the past two years significantly increased the
range of programmes and services available to respond to the needs of
drug users and potential drug users.
The Task Forces have piloted over 200 separate community-based
initiatives to complement the drug programmes and services provided 
by State Agencies, which themselves have had their funding significantly
increased in recent years. The Cabinet Committee on Social Inclusion has
given the go-ahead for the Task Forces to update their action plans and
significant funding is being made available for this purpose. This should
increase even further the range of interventions being put in place to
tackle drug misuse.
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A unique feature of the Local Drugs Task Force initiative is the intention
to “mainstream” projects which are working well and are achieving their
aims. In this instance, mainstreaming refers to the process whereby these
projects will be formally evaluated and, if deemed to be working
successfully, will continue to be funded on an ongoing basis in accordance
with agreed procedures. The process, therefore, copperfastens the role
being played by community and voluntary organisations in responding to
drug misuse at local level.
I would like to congratulate everyone involved in the Local Drugs Task
Force process. In particular, I would like to thank the Task Force members
for their energy and commitment, as well as the members of the National
Drugs Strategy Team, who have assisted and worked closely with the Task
Forces since their establishment. I would also like to pay tribute to my
constituency colleague, Deputy Pat Rabbitte, and the other members of
the Ministerial Task Force which piloted this innovative and imaginative
approach under the previous administration. It is my intention to continue
to develop and expand on the excellent work which was initiated by 
that Committee.
Chris Flood, T.D.,
Minister of State for Local Development and with 
special responsibility for the National Drugs Strategy
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INTRODUCTION
INTRODUCTION
The Local Drugs Task Forces were set up in 1997 to facilitate a more
effective response to the drug problem in the areas experiencing the
highest levels of drug misuse. This was to be achieved through improved
co-ordination in service provision and through utilising the knowledge 
and experience of local communities in designing and delivering those
services.
The Task Forces comprise a partnership between the statutory, voluntary
and community sectors. They were mandated to prepare and oversee 
the implementation of action plans which co-ordinate all relevant drug
programmes in their areas and address gaps in service provision. The
Cabinet Committee on Social Inclusion allocated £10 million to support
the implementation of the initial Task Force plans, which were prepared 
in 1997. Over 200 separate measures, mainly community-based initiatives,
were funded to complement and add value to existing programmes and
services under the themes of education, prevention, treatment, aftercare,
rehabilitation and reducing supply.
In November, 1998, following an independent evaluation, the Cabinet
Committee on Social Inclusion approved the continuation of the Local
Drugs Task Forces for a further minimum two year period. The National
Drugs Strategy Team1 subsequently reviewed the operation of the Task
Forces, taking account of the findings/recommendations of the evaluator,
and reached agreement with them on a number of measures aimed at
strengthening their impact. The Minister of State for Local Development
1 The National Drugs Strategy Team was set up in late 1996 to co-ordinate a response to the drug
problem at central level. The Team, which reports to the Minister of State for Local Development and
with special responsibility for the National Drugs Strategy, Mr. Chris Flood, T.D., is specifically
mandated to assist the Local Drugs Task Forces in their work. A note on the background to the
establishment of the Team, along with its terms of reference and composition is at Appendix I.
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and with special responsibility for the National Drugs Strategy, Mr. Chris
Flood, T.D., obtained the approval of the Cabinet Committee for these
measures in July, 1999. This handbook outlines the revised arrangements
for the operation of the Task Forces, following the review.
The Cabinet Committee has allocated a further £15 million towards the
initiative over the period 2000-2001. This funding will enable the Task
Forces to update their action plans and also tackle issues which need to
be addressed on a cross-Task Force basis.
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SECTION I
LOCAL DRUGS TASK FORCE AREAS
While the use of illicit drugs is a nation-wide phenomenon, heroin abuse,
in view of its public health implications and close association with crime,
is a cause of particular concern. The Local Drugs Task Forces were set up
in the areas experiencing the highest levels of illicit drug use, in particular
the areas where heroin abuse is most prevalent. These areas are defined
on the basis of the following criteria: drug treatment data from the health
services (especially data relating to opiate dependency); Garda crime
statistics; data relating to school attendance/drop-out; and other relevant
data on the levels of social and economic disadvantage in the area. The
Local Drugs Task Force areas are:-
• Ballyfermot
• Ballymun
• Blanchardstown
• Bray
• Canal Communities (Bluebell, Inchicore, Rialto) 
• Clondalkin
• Dublin 12 (Crumlin, Drimnagh, Kimmage, Walkinstown)
• Dublin North East (Coolock, Darndale, Donnycarney, Killbarrack)
• Dublin North Inner City
• Dublin South Inner City
• Dun Laoghaire/Rathdown 
• Finglas/Cabra
• North Cork City
• Tallaght
A list of the Local Drugs Task Force chairpersons and co-ordinators is at
Appendix II.
SECTION II
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OBJECTIVES OF THE LOCAL DRUGS TASK FORCES
The overall aim of the Government’s drugs policy is to provide an
effective, integrated response to the problems posed by drug misuse. 
The key objectives of that policy are:
• to reduce the numbers of people turning to drugs in the first instance,
through comprehensive education and prevention programmes;
• to provide appropriate treatment and aftercare for those who are
dependent on drugs;
• to have appropriate mechanisms in place at national and local level,
aimed at reducing the supply of illicit drugs; and
• to ensure that an appropriate level of accurate and timely information
is available to inform the response to the problem.
In contributing to these overall aims and objectives, the Local Drugs Task
Forces were set up to develop and implement a drugs strategy for their
areas which co-ordinates all relevant programmes and addresses any gaps
in services. Of equal importance, the Task Forces provide a mechanism
which enables local communities to work closely with State and voluntary
agencies in designing and implementing that strategy.
Terms of Reference
The original terms of reference of the Local Drugs Task Forces required
them to assess the extent and nature of the drug problem in their areas
and to develop and monitor the implementation of action plans to
respond to the problem as identified. The following are their revised
terms of reference:
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SECTION II
• to oversee and monitor the implementation of projects approved
under their existing action plans;
• to ensure the formal evaluation of these projects with a view to their
“mainstreaming”, i.e. their continued funding through State Agencies
in accordance with agreed procedures (see Section VII);
• in accordance with agreed guidelines (see Section VI), to prepare
updated action plans which:
- update the area profile and take into account any changes in the
drug problem since the preparation of their original plans;
- ensure that emerging strategic issues are identified and policies 
or actions are proposed to address them; and
- provide for the implementation of a local drugs strategy, in
consultation with appropriate State Agencies and voluntary,
community and residents groups;
• to ensure appropriate representation by the voluntary and community
sectors on the Task Force;
• to identify any barriers to the efficient working of the Task Force;
• to develop networking arrangements for the exchange of information
and experience with other Task Forces, as well as for the dissemination
of best practice;
• to identify the training needs of Task Force members and take the
necessary steps to meet such needs through appropriate training
courses, etc.;
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• to take account of and contribute to other initiatives aimed at tackling
social disadvantage under the aegis of the Cabinet Committee on
Social Inclusion, including the Integrated Services Process, the Area
Partnerships, the Young People’s Facilities and Services Fund and the
Report of the Task Force on the Integration of the Local Government
and Local Development systems; and
• to provide such information, reports and proposals to the National
Drugs Strategy Team as may be requested from time to time.
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SECTION III
COMPOSITION OF THE LOCAL DRUGS TASK FORCES
The Local Drugs Task Forces represent a partnership between the
statutory, voluntary and community sectors. Their composition is 
as follows:
Chairperson
Initially, an independent chairperson was nominated to each Task Force
by the Area Partnership2 in whose area the Task Force operates. Any
subsequent vacancies are filled through nomination by the Partnership, 
in consultation with the Task Force and the National Drugs Strategy
Team. The criteria for nomination include: a relevant expertise,
knowledge and experience of the drugs issue in the area and an
assurance of the necessary time commitment to carry out the job.
Statutory Sector
The following Departments/Agencies participate in the work of the 
Task Force:
• Health Boards
• Garda Síochána
• FÁS
• Probation & Welfare Service
• Local Authorities
2 The Area Partnerships were set up in 38 disadvantaged areas around the country (including all the
Local Drug Task Force areas) under the Operational Programme for Local Urban and Rural
Development 1994-1999, to address the issue of long term unemployment, particularly in the context 
of social exclusion.
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• Youth Service (through the Vocational Education Committees)
• Education and Science3
• Social, Community and Family Affairs3
Departments/Agencies, in nominating their representatives, are required
to take account of the need to nominate persons who are at a sufficiently
senior level, or have access to people in their organisation who are in a
position to influence policy. Departments/Agencies are also required to
ensure that their representatives’ work with the Task Forces is seen as
part of their core duties and that they have the necessary time available
to them to enable them to undertake their role effectively (see Section
IV). To ensure a strong and active role by the statutory sector, it is
important that statutory representatives have proper organisational
supports and the necessary back-up arrangements.
3 While not originally represented on the Task Forces, in view of the key role which initiatives operating
under their aegis play in responding to drug misuse, arrangements are being put in place to enable
these Departments to participate in the work of the Task Forces, having regard to the fact that they do
not have regionalised structures.
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SECTION III
Community Sector
Six community representatives were nominated to each Task Force by the
relevant Partnership, following wide consultation among local community
groups. In some instances, this was achieved through the establishment 
of community fora who, in conjunction with the Partnership, nominated
representatives based on criteria which included:
• having an appropriate and adequate geographic spread of
representation for the area;
• giving priority to groups with a strong track record in community
development;
• nominating individuals who have the relevant knowledge and
experience of the drugs issue necessary to play a full and productive
role on the Task Force; and
• nominating representatives who have the active support of the
communities they represent. 
These criteria continue to apply when replacing community
representatives for any reason, e.g. at the end of their term, 
resignations, etc.
Voluntary Sector
Initially, each voluntary agency delivering a drug treatment service in the
area was invited to nominate one representative to that Task Force,
subject to a maximum of two voluntary representatives per Task Force. 
In order to strengthen voluntary representation on the Task Forces -
particularly as voluntary treatment agencies do not operate in all areas -
voluntary representatives will in future be nominated following
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consultation between the voluntary drug treatment sector and the Local
Drugs Task Force. Criteria for nomination will include:
• giving priority to groups with a strong track record in drug treatment;
• nominating individuals who have the relevant knowledge and
experience of the drugs issue necessary to play a full and productive
role on the Task Force;
• nominating representatives who have the active support of the
voluntary drug treatment sector; and
• recognising the need for representatives to report to the voluntary
drug treatment sector as a whole rather than solely to their own
voluntary agency.
Elected Representatives
While not initially included in the membership of Task Forces in all areas,
local elected representatives are now being invited to formally participate
in the work of the Task Forces. In addition to addressing the democratic
deficit, the participation of elected representatives, on the same basis as
other members, allows them to bring their considerable experience and
intimate knowledge of the area to bear on the process. It also affords
them an opportunity to influence the drugs strategy being developed 
by the Task Force for the area and to gain community support for it.
Up to four elected representatives will be nominated to each Task Force
through the relevant local authorities, although Task Forces can agree
alternative arrangements with their elected representatives to suit local
circumstances.
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SECTION III
Other Representation
Relevant vocational groups (e.g. general practitioners, pharmacists,
teachers, clergy, etc.) have a vital role to play in the work of the Task
Forces. This can be achieved through their participation on the
appropriate sub committees and working groups of the Task Force.
There is also scope for drug users to make a valuable contribution
through, for example, the use of drug user fora, which can act as a
mechanism for consultation between Task Forces and local drug users.
Duration of Appointment/Review of Representation
There are no formal guidelines regarding the duration of appointment of
Task Force members. Generally, their tenure should be such as to ensure
continuity and consistency in the approach of the Task Force in responding
to the drug problem in its area.
In this regard, statutory representatives continue to be nominated to 
the Task Forces by their agencies, having regard to those agencies’
responsibilities towards the initiative as outlined in Section IV.
It is equally essential that the chairperson and community/voluntary
representatives continue to retain the confidence of both the Task Force
and the sectors they represent. 
The Task Forces are required to ensure that appropriate procedures are 
in place to assist them with the regular review of representation. Rules 
for attendance at Task Force meetings and sub-committee/working group
meetings should also be agreed, in accordance with normal procedures.
SECTION IV
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ROLE OF LOCAL DRUGS TASK FORCE MEMBERS
The Local Drugs Task Forces were given a key role by the Government in
responding to the drug problem. Their composition reflects the need to
ensure locally-based responses that complement existing or planned drug
programmes and services. In this context, the part played by individual
Task Force members in representing their particular agencies or sectors 
is pivotal to the success of the initiative.
Role of Chairperson
The chairperson’s role is twofold: firstly, to lead the Task Force and,
secondly, to facilitate its meetings.
Leading the Task Force:
The key responsibilities which arise here are:
• taking responsibility for helping everyone involved in the group to
work well together towards achieving the Task Force’s aims;
• acting as spokesperson and representing the Task Force, as
appropriate;
• helping the Task Force to develop policies and priorities and ensuring
that it continues to operate to these;
• helping to resolve conflict; and
• making emergency decisions between meetings, where necessary, 
in accordance with procedures agreed by the Task Force.
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SECTION IV
Facilitating meetings:
This involves:
• helping members to work well together in discussing and deciding
issues;
• encouraging all members to participate fully and ensuring that they
are heard;
• suggesting ways of dealing with conflict and ensuring that it is not
ignored; and
• ensuring that members are aware of their responsibility to make
meetings effective.
Role of Statutory Representatives
The State Agencies were given a unique opportunity to participate in
the Local Drugs Task Force process and to assist in the preparation and
implementation of integrated strategies to address the drug problem 
at local level. The representatives of these agencies contribute to this
process in a number of ways:
Supporting the work of the Task Forces:
Bringing Task Force projects to implementation stage and further
developing the role of the Task Forces is a demanding task that requires
significant support from the State Agencies. This needs on-going
commitment, both at the level of the individual and the organisations
they represent. Such commitment is essential if the various measures 
in the action plans are to be implemented and the plans themselves
further developed.
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Statutory representatives are expected to carry out their role in a pro-
active way, bringing information from their organisations to the Task Force
and looking at ways in which their organisation can develop innovative
local responses to the drug problem. They must be mandated to act on
behalf of their agencies in the planning, implementation and monitoring
of the Task Force action plan.
While statutory representatives have particular fields of expertise, they
are expected to be familiar with all aspects of Task Force activities and
the strategies being adopted to address the drug problem in their area.
This enables them to participate actively in the work of the Task Force,
which should be considered as part of their core duties. They must attend
meetings regularly and involve themselves in other Task Force activities,
including participation in sub committees and working groups as required.
Monitoring projects being funded through their agencies:
There should be no undue delay in setting up projects which are
approved funding. This includes the prompt processing of payments by
State Agencies to project promoters, while at the same time observing 
the need for financial accountability and proper procedures. Statutory
representatives are expected to monitor the situation in relation to
projects being funded through their own organisations and ensure that
any emerging problems are highlighted at an early stage, so that
appropriate remedial action can be initiated.
Support for emerging community groups:
As already mentioned, statutory representatives are expected to take an
active interest in the implementation and monitoring of projects within
their own area of expertise and provide any input which may be of
20
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SECTION IV
assistance to the promoters of such projects. This is particularly important
in areas where new groups are emerging as project promoters, or where
local community structures are not well developed. Such groups can
experience difficulty in complying with application procedures in relation
to documentation, e.g. signing contracts, financial procedures, etc.
Where such difficulties become apparent, statutory representatives are
expected to ensure that the matter is brought to the attention of the Task
Force co-ordinator, so that the necessary support can be arranged. Where
possible, the representatives are required to lend whatever practical
assistance they can in relation to such matters.
Networks:
The Task Force process is providing a valuable opportunity to share ideas
and experiences across a broad range of sectors and activities. Statutory
representatives should actively engage with their counterparts on other
Task Forces and representatives of other agencies, whenever possible, 
to maximise this potential benefit, broaden their understanding of the
issues involved in addressing the drug problem and share best practice 
in relevant areas.
Role of Community/Voluntary Representatives
There are two key elements in the role of the community/voluntary
representative:
• bringing the benefit of his or her own local knowledge and experience
of the drugs issue to the Task Force; and
• acting as a representative on behalf of the local community or
voluntary sector at the Task Force.
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People who are selected as community representatives should be active
within their communities, have some experience of local drugs issues and
have a commitment to dealing with the problem. The extent of that
experience will vary from area to area, as different communities are at
different stages of development in responding to the drugs issue.
However, as the work of the Task Forces continues, it is likely that the
experience of newer members will increase, especially through their
involvement with various projects and initiatives.
Equally, the voluntary representatives should belong to a voluntary
treatment agency which is delivering a drug programme in Task Force
areas generally. They should have a knowledge of the drug problem in 
the area to which they have been nominated, as well as a commitment 
to dealing with that problem.
It is essential that the expertise and experience of the community and
voluntary sectors is clearly recognised by the other sectors involved.
The community/voluntary representatives are not members of the Task
Force as individuals, nor are they there to represent the interests of any
particular organisation. Rather, they are nominated as persons who can
represent the interests of the wider community/voluntary sectors. Their
role, therefore, is to bring the view of these sectors to the Task Force and
keep their sectors informed on the Task Force’s work.
There are three key processes involved in carrying out that role:
• providing information to the local community or voluntary sector;
• organising and facilitating discussion and debate in the local
community or voluntary sector; and
• providing feedback to the Task Force. 
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SECTION IV
The existence of well-developed community structures facilitates the
effective performance of this role. However, community representatives
are, in some instances, acting for communities where no such structures
exist. In representing the views of the local community, representatives
will often have to deal with strongly divergent views.
Equally, there is a need for a strong voluntary sector network, through
which the voluntary representatives can report. They must also be able 
to put forward, in a fair and balanced manner, the diverse views which
may exist between the different components of that sector.
In order to represent the views of the local community and voluntary
sector, the representatives need to be able to feed information back 
to Task Force meetings in an effective way. This involves their active
participation not only in full Task Force meetings but also on any sub
committees or working groups of the Task Force. Community/voluntary
representatives should also be part of any delegations to meet the
National Drugs Strategy Team or other relevant bodies.
The community/voluntary representatives should work together within
their respective groupings on summarising and presenting information to
the Task Force and in promoting and arguing their case, where necessary. 
Role of Elected Representatives
Elected representatives can play an important role in winning support in
local communities for the strategies being pursued by the Task Forces. 
In this regard, it is imperative that they are fully appraised of the Task
Forces’ strategies and the reasons underpinning them. In this way, they
can assist the Task Forces in overcoming misapprehensions and fears
around the provision of drug programmes and services in their areas.
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Representatives who are nominated to the Task Forces are expected to
liaise with and encourage other elected representatives in their areas to
support the work of the Task Forces.
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SECTION V
SUPPORTS FOR THE LOCAL DRUGS TASK FORCES
A range of supports have been put in place to assist the Task Forces in
their work.
Co-ordinator
A co-ordinator was appointed to each Task Force. The co-ordinators are
employed by the Health Boards and nominated to the various Task Forces,
in consultation with the Task Forces themselves. While the Health Boards
employ the co-ordinators and have responsibility for their conditions of
employment and salaries, the co-ordinators are assigned full time to the
Task Forces for as long as the Task Forces are in existence. The following
are the duties of the co-ordinator:
• to profile all existing or planned services and resources available in the
local area to combat drugs;
• to review, update, prioritise and amend the local drugs strategy in
consultation with the Local Drugs Task Force, to ensure its objectives
are met;
• to provide such information reports and proposals to the Local Drugs
Task Force, National Drugs Strategy Team and State Agencies, as may
be appropriate;
• to facilitate multi-sectoral collaboration through increased participation
of drug service provision within the Local Drugs Task Force area;
• to support community, voluntary and statutory groups in establishing
needs and prioritising responses;
• to disseminate information on local drugs issues, Local Drugs Task
Force plans, services and other responses;
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• to liaise with key interest groups, service providers, Government
Departments and other relevant groups;
• to contribute to the establishment of mechanisms for monitoring and
evaluating Local Drugs Task Force projects;
• to ensure that proper evaluation procedures for projects are put in
place so as to ensure their effective delivery, based on agreed
objectives as outlined in the local area plan;
• to initiate research, as required, and gather information that will inform
organisational, local and national policy development; and
• to co-ordinate other such activities as the Local Drugs Task Force
deems necessary or appropriate to furthering its drugs strategy.
Administrative and Other Back-up Support
The Health Boards have primary responsibility for providing and maintaining
adequate administrative supports to the Task Force co-ordinators. However,
a flexible approach is taken and the ability of other State Agencies to assist
in the provision of back-up services and accommodation is explored, where
appropriate, having regard to the level of services provided by those
agencies in the area and the particular needs of the Task Force.
Task Forces are also permitted to include in their action plans, proposals for
whatever additional supports are necessary to enable them to implement
the plans, e.g. the employment of development workers for the duration of
specific administrative/co-ordination tasks, to assist with getting projects off
the ground, or to assist with the development of new plans. 
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SECTION V
Supports for Community Sector
Community representatives have an important role in providing
information to and consulting with local communities in relation to drugs
issues, as well as re-assuring them that the Task Force is operating on the
basis of genuine partnership.
A crucial part of that role is their coming together to identify issues 
of common concern, so as to have a joint input and impact on policy
development. They are assisted in this role by the Dublin Citywide Drugs
Crisis Campaign, which is an umbrella group for community organisations,
trade unions and voluntary groups tackling the drug problem. Citywide,
which is in the process of establishing networks nationally, facilitates
training and regular meetings of the Task Force community representatives.
Supports for Voluntary Sector
In line with the desire to strengthen the role of voluntary agencies on the
Local Drugs Task Forces, the National Drugs Strategy Team is encouraging
the formation of a network of voluntary treatment agencies, who can then
assess the supports which they need to play their full part in the process.
Training
Training for Task Force members is essential to the success of the
initiative, particularly as representatives from the voluntary, community
and statutory sectors are being asked to work together in a new and
innovative setting.
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The Task Forces have been asked to identify the training and
development needs of their members, with a view to determining how
these needs can best be met. These might include, for example:
• training for statutory representatives in relation to
voluntary/community issues or services; or
• training for voluntary/community representatives in relation to
statutory services, related procedures and project management.
A joint sub committee of the National Drugs Strategy Team and the
National Assessment Committee, which was set up under the Young
People’s Facilities and Services Fund, has been established to prepare 
a Directory of existing training courses in the drugs area and to identify
gaps in training provision and formulate proposals as to how these might
be addressed. The Directory on Training in the Drugs Area is available on
request from the National Drugs Strategy Team and/or the Department 
of Tourism, Sport and Recreation.
Administrative Budget
Each Local Drugs Task Force was allocated a budget to cover expenses
such as travel and family care expenses for community representatives;
training; advertising; postage; stationery; convening public meetings; etc.
This funding is additional to the supports offered by State Agencies, who
are expected to assist Task Forces in whatever way possible (e.g.
providing premises for meetings, etc.). The Task Forces received an initial
administrative budget of £10,000 in 1997 and a similar amount is being
made available to assist them over the next two years. The procedures
governing the administration of this budget are set out at Appendix III.
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SECTION V
Development Fund
It is considered essential that each Task Force should have funds available
to enable it to respond promptly to new or emerging situations in its area,
or to assist new community or voluntary groups by way of “seed” funding.
Each Task Force received an initial development fund of £10,000 for this
purpose and a further budget of £15,000 is being made available over the
next two years. The procedures governing the use of this fund are set out
at Appendix IV.
Networking
Networking is an integral part of the process in that it allows the Local
Drugs Task Forces to share their experiences and come to agreed
solutions on common problems. Networking is facilitated in a number 
of ways as follows:
Chairpersons Group:
The Chairpersons of the Task Forces hold ad-hoc meetings, as the need
arises. Secretarial support and facilitation is available to them for this
purpose. The National Drugs Strategy Team also meets the Chairpersons
group periodically.
Co-ordinators Group: 
The Task Force Co-ordinators have formed a network group which meets
regularly to discuss matters of common interest. The National Drugs
Strategy Team meets regularly with this group. 
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Joint Meetings:
It is planned to hold annual meetings between the National Drugs
Strategy Team and the full Task Forces, to review progress in
implementing the drugs strategy and consider any issues arising.
Arrangements are also in place for the State Agencies to brief the Task
Force Chairpersons and Co-ordinators in relation to their policies and
strategies for tackling the drug problem.
State Agency Groups:
All statutory representatives hold group meetings to ensure that
individual concerns are addressed and that progress is monitored
centrally. Statutory representatives are also expected to meet in plenary
session as required, to ensure that a uniform drugs policy is reflected
throughout all agencies and that there is an awareness of developments.
National Drugs Strategy Team:
The relationship between the National Drugs Strategy Team and the Task
Forces is perceived by all involved as being very effective. In order to
ensure that this continues, a liaison person from the Team has been
assigned to each Task Force.
Newsletters:
The National Drugs Strategy Team produces a newsletter for circulation
to all Task Forces, to keep them informed of progress, successes,
developments, issues, models of good practice, etc.
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SECTION V
Linkages with Other Bodies
Effective co-ordination with other bodies and complementary initiatives 
is ensured through the following arrangements:
Area Partnerships:
Partnerships, in consultation with the Task Forces, have responsibilities 
in relation to nominating Task Force chairpersons and community
representatives. They also channel funding to certain projects and
administer the Task Force administrative budgets.
Some Partnerships have very close working relationships with the Task
Forces and are represented at Task Force meetings. Where this is not
already the case, the Task Forces are being encouraged to formalise
arrangements for further co-operation, taking into account any future
developments in local development structures.
Young People’s Facilities & Services Fund:
The Local Drugs Task Forces nominated the chairs of the development
groups which were set up in Task Force areas to prepare facilities and
services plans under the Young People’s Facilities and Services Fund.
These plans were submitted to the Task Force, prior to their submission 
to the National Assessment Committee which evaluated them and
recommended funding to support their implementation.
The development groups are responsible for overseeing the effective
implementation of the plans. The Local Drugs Task Forces receive regular
reports from them on the implementation of the plans and must be
consulted in relation to any major changes to the plans. 
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Integrated Services Process:
In the areas where this process is currently operating on a pilot basis
(Fatima Mansions, Dolphin House, St Michael’s Estate, St. Teresa’s
Gardens, Jobstown, Dublin’s North East Inner City), the work of the Local
Drugs Task Forces is taken into account in the context of co-ordinating all
relevant programmes and services, including those responding to drug
misuse.
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ACTION PLANS OF THE LOCAL DRUGS TASK FORCES
Initial Action Plans
When the Local Drugs Task Forces were set up in 1997, they proceeded to
prepare action plans to respond to the drug problem in their areas. £10
million was allocated to support the implementation of these plans, on foot
of which over 200 separate initiatives received funding. These initiatives
were mainly community-based and were designed to complement and add
value to the drug programmes and services already being provided or
planned by the State Agencies.
Initiatives in the Action Plans
The initiatives in the Task Force plans can be categorised under the broad
themes of education, prevention, treatment, rehabilitation and reducing
supply. Examples of the types of measures funded include:
• research into the extent and nature of the local drug problem, with 
a view to assessing the needs of local drug misusers;
• the development of materials for delivering drug awareness messages
relevant to local circumstances (e.g. videos, information leaflets,
pamphlets, comics, painting books, etc.);
• the setting up of local information and advice centres for drug misusers
and their families;
• measures to target special client groups which normal drug information
services may not reach (e.g. early school leavers, travellers, etc.);
• the establishment of Community Drug Teams, to provide a holistic,
inter-agency response to the needs of local drug misusers;
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• “stay at school” projects and after-school activities, aimed at children
involved or at risk of becoming involved in drugs;
• the development of activities aimed at “at risk” children and young
people outside the school setting (in youth clubs, etc.);
• the development and/or expansion of premises through which
community-based drug programmes and services can be delivered;
• the provision of training for community groups and individuals, to
enable them to work with drug misusers and their families;
• the provision of training on drug issues for local teachers, youth
workers, Gardai and other professionals;
• ensuring that drug misusers have access to a continuum of
treatment/rehabilitation options to meet their diverse needs;
• the development of programmes and services for stabilised drug
misusers, with the aim of fully re-integrating them into the community,
including the use of initiatives, such as Community Employment, to
achieve this aim;
• the provision of support for families or the extended families of drug
misusers, through advice and assistance;
• the appointment of “link workers” to assist drug misusers in accessing
services at critical transitional periods (e.g. on leaving prison, moving
from rehabilitation towards training/employment, etc.);
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• the development of new or specific services to cater for the diverse
needs of drug misusers (e.g. crèche facilities for single parents,
residential drug treatment/rehabilitation centres where parents can
bring their children with them, etc.);
• the development of initiatives to allow local communities to participate
in estate management/community policing issues around the supply of
drugs in their areas; and
• the establishment of mediation fora with a view to resolving local
issues around supply in a balanced and equitable fashion.
Updated Action Plans
The next phase of the work of the Task Forces involves the preparation of
updated action plans and the Cabinet Committee on Social Inclusion has
allocated a further £15 million for this purpose over the period 2000-2001.
This funding will also support responses to issues of a cross-cutting nature
which impinge on the work of the Task Forces generally. 
The following guidelines are not necessarily exhaustive but have been
issued to assist the Task Forces in updating their plans.
Guidelines for Preparation of Updated Action Plans
The updated action plans should at least contain the following elements:
Part I: Review of progress in implementing the existing plan.
Part II: Development of a revised strategy.
Part III: Development and prioritisation of specific proposals to give 
effect to the revised strategy.
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Part I: Review of progress in implementing the existing plan
The updated plan should, as a first step, review progress to date in
implementing the existing Task Force strategy. This review should set out,
in concise terms:
• the objectives which the Task Force sought to achieve in its original
plan;
• the extent to which those objectives have been achieved; and
• the Task Force’s views on the factors which impacted on progress in
achieving its objectives.
This part of the plan should contain an objective assessment of the
progress made by the Task Force in achieving its original aims. It should
review the progress made in implementing the various projects and,
where possible, indicate the reasons why some projects commenced
quickly and appear to be working well, while others have not yet
commenced or are unlikely to proceed at this point.
Where new proposals have been substituted for projects which are not
proceeding, the rationale for doing this should be explained and the
updated plan should indicate how the need which the original proposal
was designed to meet will now be addressed. The Task Force should also
take account of the findings/ recommendations emanating from the
formal evaluation of projects being funded on foot of the original plans,
with a view to applying the lessons learned from that process.
Part II: Development of a revised strategy
Based on its experience in implementing its original plan and the lessons
learned from that process, the Task Force should then proceed to
examine what revisions are now necessary to its overall strategy.
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The over-riding aim should be to provide a strategic, co-ordinated
response to the drug problem in the Task Force area, through the
development of a single, integrated plan, which all organisations and
agencies - statutory, voluntary and community - support and are
committed to implementing.
Part II of the plan, therefore, should seek to do this under the following
headings: 
• an outline of the current extent and nature of the drug problem in the
area;
• a profile of current or planned service provision;
• an assessment of whether current/planned service provision meets
current or anticipated needs;
• the development of a revised strategy, with particular reference to
addressing any gaps in service provision and eliminating duplication 
or overlap.
The following sections outline in broad terms what should be included in
the updated plans under the above headings.
Outline of the current extent and nature of the drug problem in 
the area
The updated plan should profile, as accurately as possible, the current
extent and nature of the illicit drug problem in the area. This should
include an assessment of likely trends in the coming years. In compiling
the profile, the Task Force should ensure that all contacts local drug 
users have with treatment and other relevant statutory, voluntary and
community services are included. In doing this, however, all reasonable
steps should be taken to prevent double counting.
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The statutory representatives on the Task Force - while having regard to
data protection and any other relevant legislation - should ensure that all
relevant information available to their organisations is provided to the
Task Force for this purpose. 
Where a Task Force proposes to conduct or commission research into the
nature, extent or prevalence of drug misuse in its area, it is important that
it has regard to accepted norms for the conduct of such research, taking
into account the need to produce objective, valid and comparable data. 
It would be important, therefore, that research is conducted on the basis
of a standardised approach and the Health Research Board should be
consulted for guidance on this issue.
Profile of current or planned service provision in the area
The updated plan should set out the current level of service provision in
the area to respond to the drug problem. In addition to all projects being
developed through the Task Force (as outlined in part I of the updated
plan), this should include other relevant statutory, voluntary and
community programmes and services. It should also include all planned
programmes and services.
The statutory representatives should ensure that all current or proposed
programmes and services delivered by their agencies are brought to the
attention of the Task Force. The Task Force should also contact any
relevant organisations or agencies not represented on it (e.g. the local
Partnership) and invite them to give details of any relevant initiatives
which they are operating or have planned. 
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An assessment of whether current/planned service provision meets
current or anticipated needs
Having examined the nature and extent of the local drug problem and
profiled the services being delivered to respond to it, the Task Force
should then form a view as to the extent to which current service
provision meets the identified needs, under the following headings:
• drug awareness/education/prevention;
• treatment programmes and services for drug misusers;
• rehabilitation programmes and services for stabilised or recovering
drug misusers; and
• community involvement in issues relating to reducing supply at local
level.
Task Forces should determine whether the diverse needs of current or
potential drug misusers are being met or are capable of being met under
existing plans and programmes.
Development of a revised strategy, with particular reference to
addressing gaps in service provision and eliminating duplication 
or overlap
Having profiled the extent of the problem, the current or planned level of
service provision and identified the needs which are not currently being
met, the Task Force should then decide what measures are now necessary
to address gaps in programme or service provision. Specifically, the
updated plan should:
- in relation to drug awareness/education/prevention: seek to develop
a range of measures to alert people, particularly young people, to the
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dangers of substance abuse and prevent them from becoming involved 
in drugs. In developing appropriate measures, cognisance should be taken
of the need to avoid overlap or duplication with other similar or
complementary initiatives which focus on diverting young people away
from drug misuse, in particular the Young People’s Facilities and Services
Fund, the Area Action Plan of the local Partnership, the Disadvantaged
Youth Scheme (operated by the VEC’s) and Garda Diversionary Projects;
- in relation to treatment programmes and services: identify any gaps 
in service provision, with a view to ensuring that there is a continuum of
treatment options available to drug misusers in the area. Proposed new
services should complement those already provided or planned by the
Health Board, as well as voluntary, community and other relevant
organisations. The overall aim should be to ensure that the diverse needs
of different drug misusers are fully catered for in terms of the type of
treatment provided, the settings in which it is delivered and providing 
the other back-up and supports needed by the client;
- in relation to rehabilitation programmes and services for stabilised
or recovering drug misusers: identify gaps in the rehabilitation
programmes currently available or planned and propose new services to
address these gaps. As more and more drug users present for treatment,
considerable strain is being put on the rehabilitation services currently
available. The Task Force, therefore, should give priority to the
development of these services, having regard to the proposals contained
in their original plans and their experience in attempting to implement
them.
- in relation to community involvement in issues on reducing supply 
at local level: the Task Force should develop strategies to allow local
communities to work in close co-operation with the relevant authorities
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(e.g. Gardai, Local Authorities, etc.) in estate management and
community policing initiatives, aimed at reducing the supply of drugs 
in the area in a balanced and equitable fashion. 
Part III: Development and prioritisation of specific proposals to give
effect to the revised strategy
Having drafted a coherent strategy to respond to the local drug problem,
the next step is to develop and prioritise a series of specific proposals to
give effect to that strategy.
In preparing these proposals, the Task Force should bear in mind that
initiatives to fill gaps in service provision do not necessarily have to be
funded through the Task Forces and the onus on State Agencies to deliver
programmes and services in their own areas of responsibility remains. The
Task Force should take into account the review carried out in Part I of the
updated plan and make any adjustments to its original proposals which it
feels are necessary at this point in order to achieve the objectives of the
revised strategy.
All proposals should be fully costed and prioritised. The updated plan
should set out concisely the objectives of the proposals being put forward
and, as far as possible, set clear targets to be achieved. In this regard, the
Task Force should indicate, in precise terms, the proposed inputs and
expected measurable outputs, outcomes and impacts in relation to each
proposal and how it integrates into the overall drugs strategy.
The Task Force should also pay particular attention to identifying any
unnecessary overlap or duplication in current or planned service
provision, proposals for the elimination of which should be agreed
between the relevant parties and included in the plan.
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Cross-Task Force issues
In preparing its updated plan, the Task Force should identify issues which
- while not impacting directly or exclusively on its area - are nevertheless
important in developing an integrated, coherent response across all Task
Force areas. An example of this is the issue of homeless drug users, a
problem which some Task Force areas “export” while others “import”.
The Task Force should:
• identify which issues need to be examined in this context; and
• make recommendations as to how they might best be addressed.
The National Drugs Strategy Team will then consider these issues and -
following further consultation with the Task Forces - will make
recommendations to the Minister of State on the matter.
Process by which the updated action plan should be developed
A comprehensive consultation process is essential when preparing the
updated plan. This should include consultation with local statutory,
voluntary and community organisations which, although not represented
on the Task Force, are nevertheless delivering programmes and services 
in the area relevant to addressing the overall drug problem. Consultation
should take place in relation to:
• profiling the nature and extent of the local drug problem;
• compiling an inventory of current and planned service provision, 
with a view to filling gaps and eliminating overlap or duplication; and
• identifying the measures now required to ensure that an integrated
drugs strategy is developed for the area.
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It is vitally important that local communities have an opportunity of
inputting into the planning and development of proposals affecting their
areas if they are to take ownership of the projects once they commence. It
is recommended, therefore, that the Task Forces engage in a widespread
process of public consultation in preparing their updated plans. 
Timeframe for preparation of the updated action plans
No specific deadline is being imposed for the submission of the updated
plans. The time taken by Task Forces to complete their plans will not
affect the eventual level of funding provided to implement them. Funding
to implement the plans will be available from January, 2000 and it is
anticipated that plans will begin to be submitted after that date.
Assessment of updated plans
The updated plans will be assessed by the National Drugs Strategy Team
in line with the criteria outlined below, while having regard to the extent
and nature of the drug problem in the area and the merit of the measures
being proposed.
The Team’s recommendations in relation to funding to implement the
recommended projects will be submitted to the Minister of State, who, in
turn, will make his recommendations to the Cabinet Committee on Social
Inclusion.
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Criteria for assessing plans
The following are the criteria which will be used to assess the updated
plans:
• the extent to which the plan is area-based, integrated and maximises
the use of existing resources;
• whether the measures proposed are additional and complementary to
existing or planned programmes and services - statutory, voluntary and
community - in the area;
• whether the proposed measures link effectively with complementary
initiatives, existing or planned, including the Young People’s Facilities
and Services Fund and the Area Action Plan of the local Partnership;
• whether the Task Force has clearly demonstrated a partnership
approach to filling gaps in service provision and eliminating duplication
or overlap;
• whether it has been clearly demonstrated that the proposed
programmes and services meet the identified needs of the area, having
regard to the extent and nature of the local drug problem, the diverse
needs of the target group and the current or planned level of service
provision;
• whether the proposed measures accord with the aims, objectives and
targets of the overall initiative;
• the extent to which the proposed projects have the potential to be
successfully “mainstreamed” (see Section VII), following full piloting
and evaluation;
• whether the promoters have demonstrated the capacity to deliver the
proposed projects;
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• whether the proposed projects are viable and sustainable;
• whether the plan incorporates new, innovative approaches in
responding to the drug problem, which are capable of being replicated
elsewhere;
• whether the proposed projects have been fully costed and prioritised;
• whether the proposed projects set out clear aims, objectives and
targets, in terms of inputs and expected measurable outputs, outcomes
and impacts;
• whether the Task Force has demonstrated a wide consultation process
in the development of the plan; and
• the mechanisms proposed to ensure the effective implementation and
monitoring of the approved proposals.
Technical assistance
A technical assistance budget of up to £10,000 is available to each Task
Force, if required, to assist it in preparing its updated plan. To access this
funding, the Task Forces should submit their proposals to the National
Drugs Strategy Team, for consideration.
Information sessions
Taking account of the experienced gained to date is an important part 
of the preparation of the updated plans. Therefore, the National Drugs
Strategy Team has arranged a series of information sessions for the Task
Forces to facilitate the dissemination of best practice under the various
themes to be addressed in the plans.
SECTION VII
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MONITORING/EVALUATION/MAINSTREAMING
OF LOCAL DRUGS TASK FORCE PROJECTS
Evaluation
Evaluation is an integral part of any programme or initiative. As well as an
evaluation of the overall process to measure its success or otherwise, it is
proposed to evaluate the individual projects being funded through the
initiative, with a view to mainstreaming those ones which are operating
successfully. The term “mainstreaming”, as used throughout this
handbook, refers to the process by which responsibility for the funding 
of a project transfers to the relevant State Agency in accordance with 
the procedures and protocols outlined in this section.
Funding/Monitoring Arrangements for Projects
When a project has been approved for funding, the project promoter
submits a claim form (LDTF1), via the Local Drugs Task Force, to the
relevant State Agency in order to access funding. The form should be
accompanied by a monthly cash-flow statement. Following processing 
of the claim by the State Agency, the flow of funding to allow the project
to commence begins.
A copy of the LDTF1 form, cash flow statement and explanatory note is 
at Appendix V.
Reports are submitted to the Task Force co-ordinator by the project
promoter on a quarterly basis, or more regularly where appropriate.
These record progress in relation to the project, as well as setting out 
the position in relation to expenditure and the drawdown of funding.
If it becomes apparent that problems are developing with a particular
project, the statutory representative on the Task Force within whose remit
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the project falls should, in association with the Co-ordinator, enquire into
the difficulties and report back to the Task Force and State Agency. The
Task Force as a whole must agree a position where continuing difficulties
persist. Where appropriate, the National Drugs Strategy Team should be
consulted. Where there is any evidence or suggestion of financial
impropriety, the State Agency should be informed immediately.
Interim Funding
Task Force projects have an initial one year timeframe. However, as a
general principle, projects which have exhausted their initial budgets, 
but are considered by the Task Force to be meeting their objectives, will
continue to be funded on an interim basis until such time as they have
been formally evaluated and a decision is taken in relation to their
mainstreaming. The National Drugs Strategy Team has discretion to
approve such funding.
Criteria for Mainstreaming
Projects will only be mainstreamed where they have been formally
evaluated in accordance with the agreed criteria and, following this
evaluation, there is a clear recommendation that they should continue. 
It would also be essential that any modifications recommended in the
evaluation (i.e., amended operating procedures, etc.) be put in place prior
to any project being mainstreamed.
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Evaluation Process
The evaluation process must be objective and transparent and must be
carried out by individuals with a recognised and proven track record, in
accordance with agreed criteria. The following mechanism has been put
in place to facilitate this process:
• a steering group (comprising representatives of the National Drugs
Strategy Team and the Task Forces) has been set up to oversee and
monitor the process;
• a specially appointed Evaluation Co-ordinator will devise terms of
reference for the conduct of the evaluation, along with appropriate
performance indicators and these will be approved by the steering
group; and
• a panel of evaluators will then be formed. Task Forces are free to
nominate persons or companies to this panel, provided they meet the
criteria outlined above. Task Forces can then make their selection of
evaluators from the approved panel. In the event of there being
excessive demand for the services of particular evaluators, the steering
group will determine their assignment.
Evaluation Criteria for Projects
Over 200 projects were approved for funding on foot of the initial Task
Force plans. There is a wide variation in the range, type and size of these
projects. From a financial viewpoint, projects can be divided into three
types: those costing over £50,000 per annum; those costing between
£10,000 and £50,000 per annum; and those costing less than £10,000 per
annum. The majority of projects were set up with a view to being
ongoing, but some were once-off.
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Acknowledging the wide variability of projects (including the fact 
that they address the drug problem under different themes, i.e.
education/prevention, treatment, rehabilitation and community
policing/estate management), it would be difficult to devise an evaluation
framework that would equally suit all projects. It will be necessary,
therefore, to develop a process that can be applied in a flexible manner,
depending on the type of project. More rigorous evaluations will take
place with the more expensive projects.
Guidelines as to how the evaluations are carried out, along with the
ground rules, will also be necessary and these will be developed by the
steering group, in consultation with the Evaluation Co-ordinator, Local
Drugs Task Forces and project promoters as the process develops.
Protocols/Guidelines for Mainstreaming
The following protocols/guidelines have been developed to provide a
platform on which project promoters and State Agencies can enter into 
an arrangement for the continued operation and funding of projects on 
a mutually acceptable basis.
It is vitally important that both sides’ rights and responsibilities are
acknowledged and respected. The origins and ethos of individual projects
should not be lost sight of. Equally, the expertise of State Agencies should
be seen as an asset, while their responsibilities in relation to auditing of
funding, etc. must also be recognised.
The following are the protocols which must be observed if the
mainstreaming process is to work effectively:
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• prior to mainstreaming, a contract/agreement should be drawn up
between the project promoter and the State Agency and witnessed by
the Task Force, which will outline the service to be delivered by the
project and the funding, supports, etc. to be provided by the agency;
• the introduction of changes to the project - either in terms of funding,
nature, type or scale - can only be done following consultation
between the three parties involved, i.e. the project promoter, the State
Agency and the Task Force;
• the project promoter must respect the responsibility of the State
Agency to account for Exchequer funding and must, therefore, comply
with the agency’s reporting and auditing requirements; and
• the State Agency must be assured that funding at an agreed level will
be transferred to it simultaneously with its taking over responsibility 
for the project.
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NATIONAL DRUGS STRATEGY TEAM
Background
Effective action against drugs requires a sustained, co-ordinated effort
across a range of Government Departments and Agencies. This is a
critically urgent example of what the Strategic Management Initiative in
the Public Service (SMI) describes as a “cross-cutting” issue, which cannot
be met satisfactorily by any one Department or Agency. 
The National Drugs Strategy Team was established as a cross-
departmental team of the type envisaged in the SMI. The Team comprises
experienced personnel from relevant Departments and Agencies. Those
seconded to the Team have direct access to their Ministers and heads of
Department on all matters related to drugs. While accountability for
individual programmes and services remains with relevant Ministers and
their Departments/Agencies, the Team is mandated by the Government
to work together to implement its drugs strategy, so that - while
remaining officers of their parent Department or Agency - they have been
instructed to take an overview of the requirements of that strategy. 
Another important feature of the National Drugs Strategy Team is the
inclusion of one person each from the voluntary and community sectors,
who bring their extensive knowledge and experience of the drug problem
to the Team’s work. In addition to being established on SMI principles,
therefore, the Team also represents a partnership between the statutory,
voluntary and community sectors and works exclusively on the basis 
of consensus.
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Terms of Reference
The National Drugs Strategy Team’s terms of reference are as follows:
• to ensure that there is effective co-ordination between Government
Departments and State Agencies in implementing the Government’s
drugs strategy;
• in relation to the Local Drugs Task Forces:
- to oversee their establishment and assist them in their work on 
an ongoing basis;
- to draw up guidelines to assist them in preparing their action plans;
- to evaluate their plans, when submitted, and make
recommendations to the Cabinet Committee on Social Inclusion
regarding the allocation of funding to support their implementation;
• to monitor developments at local level, ensuring that the problems and
priorities of communities are being addressed at central level; and
• to contribute to the development of Government policy on drugs. 
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Composition
The following Departments/Agencies/Sectors are represented on 
the Team:
• Health and Children (chair);
• Justice, Equality and Law Reform;
• Education and Science;
• Environment and Local Government;
• Tourism, Sport and Recreation;
• Eastern Health Board;
• Garda Síochána;
• FÁS; and
• one person each from the voluntary and community sectors.
The involvement of the community and voluntary representatives helps, 
in particular, to ensure that the Team can fulfil its mandate of monitoring
closely the problems and priorities of communities in the Task Force areas
and ensuring that these are addressed at central level.
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Task Force
Ballyfermot
Ballymun
Blanchardstown
Bray
Canal
Communities
Clondalkin
Dublin N.E.
Cork
Dublin 12
Dun Laoghaire/
Rathdown
Finglas/Cabra
North Inner City
South Inner City
Tallaght
Chair
David Connolly
Mick Cowman
Seamus Maguire
Tony 
MacCarthaigh
Aileen 
O Donoghue
Michael Murphy
Cllr. James Corr
Insp. Pat
Kavanagh
(interim)
Dr. Des Corrigan
Michael Bowe
Fergus Mc Cabe
Cllr. John
Gallagher
Rosaleen Walsh
Co-ordinator
Mairéad Lyons
Hugh Greaves
Robert Markey
Chris Purnell
Enda Barron
(interim)
Peter Foran
Rebecca
Loughry 
(Co-ordinator)
Willie Collins
(Secretary)
Sheila Stone
Jim Ryan
Fiacra McGuirk
Julie
Cruickshank
Vincent
Doherty
Maurice Farnan
Address of Co-ordinator
AIDS/Drugs Service 
Cherry Orchard Hospital
Ballyfermot, Dublin 10.
18 Thomas McDonagh Tower
Ballymun, Dublin 1.
James Connolly House
James Connolly Memorial Hospital
Blanchardstown, Dublin 15.
AIDS/Drugs Service
Cherry Orchard Hospital
Ballyfermot, Dublin 10.
Ulster Bank Buildings
Monastery Road
Clondalkin, Dublin 22.
Coolock Development Centre
Coolock, Dublin 17.
Community Care Offices
Southern Health Board
St. Finbarr’s Hospital
Douglas Road, Cork.
Cherry Orchard Hospital
Ballyfermot, Dublin 10.
Centenary House
35 York Road, Dun Laoghaire
c/o Eastern Health Board
2nd Floor, Phibsboro Tower,
Phibsboro, Dublin 7
51 Amiens Street Dublin 1.
Bridge House, Cherry Orchard
Hospital, Ballyfermot, Dublin 10.
Cherry Orchard Hospital
Ballyfermot, Dublin 10.
%
/fax
%
6206412
fax-6206401
%
8424630
fax-8424466
%
8220221
fax-8221092
%
6206413
fax-6206401 
%
4579445
fax-4579422
%
8479788
fax-8479525
%
021923132
fax-021923137
%
6206422
fax-6206401
%
2803335
fax-2300690
%
8820311
fax-8820330
%
8366592
fax-8366595
%
6206438
%
6206414
fax-6206401
APPENDIX II
A Chairperson & Co-ordinator are being assigned to this newly-formed Task Force
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LOCAL DRUGS TASK FORCES
ADMINISTRATIVE BUDGET
Introduction
Each Local Drugs Task Force received an initial allocation of £10,000 to
cover certain administrative and other expenses related to its work, as
well as work carried out by Task Force members on its behalf. In July,
1999, the Cabinet Committee on Social Inclusion made a further
allocation of £10,000 to each Task Force to cover the next two years 
of their operation. These payments are administered by the relevant
Partnerships, in consultation with the chairpersons of the Task Forces.
The expenses which may be paid from this budget fall into 2 broad
categories:
• travel and family care expenses for community/voluntary
representatives; and
• other incidental expenses.
Travel and Family Care Expenses
Payments in relation to travel and family care expenses should be made in
accordance with the same guidelines and procedures which apply to the
payment of expenses to community directors of Partnership boards,
subject to the following general guidelines.
Eligibility
Expenses may only be re-couped by community representatives and, in
certain cases, by representatives of the participating voluntary agencies.
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Expenses will not be paid to representatives of State Agencies who,
should the question of expenses arise, make separate arrangements 
with their parent organisations.
Eligible Expenses
The following expenses may be recouped:
travel: the presumption is that public transport will be used except where
this is not feasible. Shared travel arrangements should be encouraged,
where possible, to keep down costs. In all cases, recoupment should be
made only on the basis of vouched invoices or receipts.
family care: expenses incurred in relation to the care of young, sick or
elderly persons, while members are attending to Task Force business, 
may be recouped on the basis of vouched invoices or receipts. 
In all cases, members should seek the clearance of the Task Force
chairperson before incurring the expense.
Ineligible Expenses
The underlying principle governing the membership of the Task Forces by
community and voluntary representatives is that they do so on a voluntary
basis. Therefore, payments by way of salary, fee payments for loss of
earnings or for giving up their own time to attend meetings, etc. are
ineligible for funding.
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Other Incidental Expenses
Funding allocated under this budget may also be used to cover other
administrative expenses incurred by the Task Force, or its members, in
relation to its work. Examples of the purpose for which the funding may
be used include expenses relating to:
• training for Task Force representatives (group facilitation, seminars,
workshops, etc.);
• vouched incidental expenses for work carried out by members on
behalf of the Task Force (e.g. telephone calls from home, etc.);
• advertising;
• postage;
• stationery;
• public meetings.
Reducing Costs
Where possible, Task Forces should make use of existing resources,
particularly those of the State Agencies. These agencies have been
requested to assist, wherever possible, in relation to items such as venues
for meetings, secretarial back up, snacks and refreshments for meetings
on their premises, etc.
Important
It should be noted that the £10,000 allocation is being made on a once-off
basis. Accordingly, arrangements should not be entered into by Task
Forces which would commit funding over and above this allocation (e.g.
entering into a long-term contract for the provision of services, etc.).
APPENDIX IV
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Development Budget
The development budget is designed primarily to respond to new situations not
covered in the Task Force plans. While the budget may be used to respond to
specific or unanticipated situations, it may also be used to provide “seed” funding
to new or emerging community or voluntary groups, as a pre-cursor to involving
them more actively in the Task Force’s overall drugs strategy at a later date.
The Cabinet Committee on Social Inclusion initially allocated a £10,000
development budget to each Task Force. In July 1999, the Committee
allocated a further development budget of £15,000 to each Task Force, 
to be accessed by them once they have used up their initial budgets.
This funding is subject to the following conditions: 
• allocations are on a once-off basis. Any group or initiative is not entitled, as
of right, to continued funding when its allocation is exhausted. However,
this does not preclude such groups or initiatives from submitting proposals
for funding at a later date, should additional funding become available;
• except in exceptional circumstances, a limit of £3,000 is placed on
individual allocations;
• the money should not be used for the recruitment of personnel, although
this does not preclude the engagement of consultancy/facilitation services
on a contract basis; 
• all allocations must be approved by the Minister of State for Local
Development and with special responsibility for the National Drugs
Strategy, Mr. Chris Flood, T.D., on foot of a recommendation from the
National Drugs Strategy Team; and
• Task Forces must show that the cost of any new proposal cannot be met
from savings within their current overall allocations.
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LDTF1 FORM
Details of Project to be funded as part of the 
Local Drugs Task Force Action Plan
Local Drugs Task Force:____________________________________________
Part A: Details of Project Promoter
Please complete each of the following sections in BLOCK CAPITALS
1.
Name of Project Promoter:
___________________________________
___________________________________
Address:
___________________________________
___________________________________
___________________________________
President/Chairperson
Name:
___________________________________
Address:
___________________________________
___________________________________
Telephone Number:_________________
Fax Number: _______________________
Tax Reference No:__________________
and/or
Charitable status (CHY No.):
___________________________________
Tax District dealing with tax affairs:
___________________________________
Date when the group promoting project
was established:
___________________________________
Secretary or Treasurer
Name:_____________________________
Address:___________________________
___________________________________
___________________________________
___________________________________
Telephone Number:_________________
Fax Number:_______________________
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2.
What are your main aims and objectives?
______________________________________________________________
______________________________________________________________
______________________________________________________________
______________________________________________________________
______________________________________________________________
3.
What are your links with other local services?
______________________________________________________________
______________________________________________________________
______________________________________________________________
______________________________________________________________
______________________________________________________________
Part B: Project Details
Location: ________________________________________________________
4.
Describe the project for which funding is being sought.
This Section must be completed and further information may be attached on a separate sheet if necessary.
______________________________________________________________
______________________________________________________________
______________________________________________________________
______________________________________________________________
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5.
6.
Who is expected to benefit from this project?
(and how many clients will take part?)
______________________________________________________________
______________________________________________________________
______________________________________________________________
______________________________________________________________
7.
How will the project contribute to addressing the drug problem in the area?
______________________________________________________________
______________________________________________________________
______________________________________________________________
______________________________________________________________
8.
Under which of the following headings does your project fall?
1. Education and Prevention:__________________________________________________
2. Treatment:_______________________________________________________________
3. Rehabilitation:____________________________________________________________
4. Other (Please Specify):_____________________________________________________
___________________________________________________________________________
a) When is the start-up date?
____________________________
b) Expected duration?
____________________________
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Part C: Funding
9.
If the project relates to a building or premises, please give details of ownership or
leasing arrangements, and your role in the management structure.
______________________________________________________________
______________________________________________________________
______________________________________________________________
10.
Please give a breakdown of the funding separating current and capital costs, and
complete the attached cashflow statement.
______________________________________________________________
______________________________________________________________
______________________________________________________________
11.
Have you already received any funding from another Government Department, State
Agency, Local Authority or any EU funded agency for this project?
______________________________________________________________
______________________________________________________________
______________________________________________________________
12.
Have you looked for any matching funding for this project?
If so, please specify the amount sought, and when the decision is expected?
______________________________________________________________
13.
Amount of funding now being sought: £_________________________________
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DECLARATION
(To be completed by the Chairperson, Honorary Secretary or Honorary Treasurer of the
Project Promoter)
On behalf of ___________________________________________________________________
I, _____________________________________________________________________________
wish to apply for funding towards the project/service named on the LDTF 1 form and 
I declare that all the information given is true and complete and to the best of my
knowledge and belief. I acknowledge that I have read the terms and conditions relating 
to “Funding to Support Projects included in the Action Plans of Local Drugs Task Forces”
and also the tax and accounting requirements of the funding agency and that I agree to
comply fully with all of the terms.
Signed: ______________________________________________________
Address: ______________________________________________________
______________________________________________________
Position Held: ______________________________________________________
Date: _____________________ Telephone No.:___________________
Certified by LDTF
(Chairperson): ______________________________________________________
Address of Witness: ______________________________________________________
______________________________________________________
Date: _____________________ Telephone No.:___________________
PLEASE NOTE THAT THE FOLLOWING SHOULD BE ENCLOSED WHERE APPROPRIATE:
1. A Tax Clearance Certificate unless you have charitable status.
2. Copy of latest audited Accounts including Balance Sheet.
3. Copy of latest Annual Report.
4. Copy of Architect’s, Contractor’s or other estimates.
Forward completed LDTF 1 form and Declaration to Local Drugs Task Force.
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FUNDING TO SUPPORT PROJECTS INCLUDED 
IN THE ACTION PLANS OF LOCAL DRUGS 
TASK FORCES 
Explanatory Note
SECTION I: Introduction
1. Proposals are approved for funding by the Cabinet Committee on
Social Inclusion, following assessment of the action plans of the Local
Drugs Task Forces by the National Drugs Strategy Team and subject 
to the conditions outlined in Section IV below.
2. The purpose of this note is:
- to describe the process by which organisations who submitted
approved proposals (hereafter referred to as project promoters) 
may access funding;
- to set out the roles of the Local Drugs Task Forces and the State
Agencies designated as channels of funding (hereafter referred 
to as Funding Agencies) in this process; and
- to outline the conditions under which funding is being allocated
3. The National Drugs Strategy Team will notify each Local Drugs Task
Force and Funding Agency of relevant proposals which have been
approved for funding, along with the amount provisionally allocated 
to support their implementation. It should be noted that the merits 
of individual proposals, together with the general level of funding, will
already have been evaluated by the National Drugs Strategy Team 
and this process need not be repeated by the Funding Agency. 
The definitive allocation will be made by the Funding Agency - in
consultation with the Local Drugs Task Force - following an examination
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of the detailed proposals and costings. This is to ensure consistency 
in approach to the allocation of funding across Task Force areas.
4. Local Drugs Task Forces and Funding Agencies should refer all matters
about which there is any doubt or disagreement to the National Drugs
Strategy Team for clarification/determination.
SECTION II: Role of Local Drugs Task Force
5. On being notified of the proposals in its plan which have been
approved for funding, the Local Task Force will:
- notify each project promoter of such approval, along with the
amount of funding provisionally allocated;
- forward the LDTF1 form to the project promoter, who will complete
it and return it to the Local Drugs Task Force. The purpose of
completing the form is to ensure that all relevant information is
available to the Funding Agency and Local Drugs Task Force in
determining:
• that the proposal meets the conditions outlined in Section IV 
below;
and
• the final allocation to be made to support it;
- examine the completed form, when returned, to ensure that all the
information requested has been furnished and that the conditions
outlined in Section IV below are complied with; and
- when satisfied that all relevant conditions have been met, certify
the form and transmit it to the relevant Funding Agency.
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SECTION III: Role of Funding Agency
6. The role of the Funding Agency will be to:
- ensure that the conditions under which funding has been approved
are complied with;
- determine the final allocation to be made to support the proposal,
in consultation with the Local Drugs Task Force, based on the
detailed proposals and costings received and taking account of the
need to ensure consistency in relation to the allocation of funding
across the Task Force areas;
- enter into a contract with the project promoter in respect of the
funding which is being allocated; and
- ensure that the projects are commenced on a viable basis within a set
period of the date of allocation, with any funding of the projects not
commenced within the period being deemed to be de-committed.
There must be a provision allowing for the recovery of any funding
previously disbursed to de-committed projects. 
7. The Funding Agency will prepare aggregate monthly profiles of
expenditure in respect of Task Force areas and submit these to the
National Drugs Strategy Team. Funding will be transferred to the
Funding Agency in advance instalments, based on the monthly profiles,
for transmission to the project promoters. Funding allocated to the
Funding Agency for this purpose should be retained in a separate
account and the Funding Agency may be required to furnish the
National Drugs Strategy Team with periodic reports of income and
expenditure in relation to that account.
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SECTION IV: Conditions Under Which Funding 
is Allocated
8. Funding to support proposals is being made available subject to the
following conditions:
- funding will be allocated to support only those proposals specifically
identified in the action plans of the Local Drugs Task Forces and
approved for funding;
- funding will be provided on the basis of supporting the projects
initially for a period of one year. Projects which require funding to
continue beyond one year will be reviewed by the Task Force prior
to the end of that period in the light of an evaluation of their
effectiveness and impact on the drug problem in the area and
taking account of whether funding should more appropriately be
made available from a different source. Continuation of funding via
the National Drugs Strategy Team will be subject to a Government
decision in relation to the process4;
- where a project is being funded on a one-year basis, as opposed to
a once-off grant, the profile of expenditure for the year (appended
to the LDTF1 form) should be completed. In such cases, funding will
be made available to the project promoter in advance instalments
based on the profiles, which may be revised by the Funding Agency
in consultation with the Local Drugs Task Force, in the light of the
examination of the detailed proposals and costings;
4 The Cabinet Committee on Social Inclusion subsequently agreed to allocate funding beyond the one
year timeframe, on the basis outlined in section VII, pending the formal evaluation of projects and 
a decision in relation to their mainstreaming.
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- the project promoter must complete the LDTF1 form and forward 
it to the Local Drugs Task Force, as well as furnishing any other
information requested by the Task Force or the Funding Agency
relevant to the proposal being funded;
- the project promoter must satisfy the Local Drugs Task Force that
appropriate management and personnel arrangements are in place
to ensure that the proposal for which funding has been allocated
can be successfully completed;
- the project promoter must comply with the tax and accounting
requirements of the State Agency through which the funding is
being channelled;
- where the project promoter proposes to recruit staff in order to
implement a proposal, it is expected that such posts will be filled
through open competition. Where a project promoter proposes to
depart from this practice, due to exceptional circumstances, the
prior consent of the National Drugs Strategy Team should be
sought;
- normal public sector tendering arrangements should be applied 
as appropriate.
